Biosimilars and Monoclonal Antibodies: Key Segments Driving...

adicionou um novo artigo Health

2025-11-04 09:51:28 -

Monoclonal antibodies (MAbs) and biosimilars represent the twin engines of growth within the rapidly expanding **China Biologics Market**, collectively driving its valuation into the multi-billion dollar range. MAbs, which target specific antigens and offer unparalleled precision in treatment, are indispensable for complex disease management, particularly in oncology and chronic inflammatory...

0 Comentários 0 Compartilhamentos 10 Visualizações 0 Anterior